Envision Pharma Group
PHILADELPHIA, PA / ACCESSWIRE / May 9, 2023 / Envision Pharma Group (Envision) today announced the appointment of Dr. Deepti Sodhi Jaggi to the Envision Board of Directors.
"We are pleased to welcome Deepti to the Envision Board of Directors," shares Meg Heim, CEO of Envision Pharma Group. "Deepti's deep experience in the technology of Artificial Intelligence (AI) and digital therapeutics in the life sciences industry will be invaluable to our mission at Envision as we continue to accelerate our global business expansion and commitment to our clients, and most importantly, impacting patient lives in a positive manner."
Dr. Jaggi's career includes over 20 years of experience in driving innovation at the intersection of life sciences, healthcare, and technology. Her expertise is in transforming businesses through software, AI/ML, and advanced analytics. Most recently, she served as Chief Strategy & Commercial Officer at Better Therapeutics, a publicly held digital therapeutics company. Before that, she served as the Global Head of Patient Insights & Solutions at Astellas Pharmaceuticals with responsibility for the Americas, EMEA, China, and Japan.
Prior to that, Dr. Jaggi served as President & Chief Medical Officer at Clinakos Inc., a Silicon Valley company at the forefront of leveraging data and AI in healthcare and life sciences. She helped grow Clinakos from startup to revenue stage, serving multiple top pharmaceutical companies.
Dr. Jaggi's previous experience includes positions of increasing responsibility and leadership at Johnson & Johnson, Genentech, Oracle, and Kaiser Permanente. She has also served as a consultant to TPG Capital and is a member of the Board of Directors for Technology Credit Union in the San Francisco Bay Area.
"I am thrilled to join the Envision Board at such an exciting time for our industry. I look forward to working with an immensely talented team to accelerate innovation in life sciences through technology and scientific solutions to positively impact patient lives," says Dr. Jaggi.
Dr. Jaggi's educational background includes a PharmD from the University of Southern California and an MBA from Stanford Graduate School of Business.
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.
Contact Information
Colleen Carter
Associate Director, Communications, Office of the CEO
colleen.carter@envisionpharma.com
1 (508) 505 8856
SOURCE: Envision Pharma Group
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/753175/Envision-Pharma-Group-Announces-Appointment-of-Dr-Deepti-Sodhi-Jaggi-to-Board-of-Directors
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Polaris Renewable Energy Announces Corporate and Bond Instrument Credit Rating8.11.2024 12:05:00 CET | Press release
TORONTO, ON / ACCESSWIRE / November 8, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") is pleased to announce that international credit rating agency S&P Global Ratings has assigned corporate credit and bond instrument ratings of BB- with Stable Outlook to Polaris. About Polaris Renewable Energy Inc. Polaris Renewable Energy Inc. is a Canadian publicly traded company engaged in the development, construction, acquisition, and operation of renewable energy projects in five countries in Latin America and the Caribbean. The Company's operations include a geothermal plant (~82 MW), four run-of river hydroelectric plants (~40 MW), three solar (photovoltaic) projects in operation (~35 MW) and one wind park (26 MW) following closing of the Puerto Rico acquisition. For more information, contact: Investor Relations Polaris Renewable Energy Inc. Phone: +1 647-245-7199 Email: info@PolarisREI.com SOURCE: Polaris Renewable Energy Inc. View the original press release on ac
MANAMAURI, the High-Quality Energy Drink Brand, Joins EastBridge Global Investments for Major International Expansion8.11.2024 10:00:00 CET | Press release
The acquisition will fuel Manamauri's global expansion with new production facilities, extended product lines, and a continued commitment to supporting emerging sports. BRUSSELS, BELGIUM / ACCESSWIRE / November 8, 2024 / MANAMAURI, the energy drink brand known for its commitment to high quality and smart pricing, has officially finalized an acquisition agreement with a subsidiary of EastBridge Global Investments. This strategic partnership empowers MANAMAURI to scale globally, remaining true to its founding values of exceptional product standards, accessibility, and support for emerging sports talent. MANAMAURI LOGO MANAMAURI LOGO "MANAMAURI was established with a clear mission: to deliver premium energy products with an intelligent pricing model, making quality accessible without compromising our values," shared a spokesperson for MANAMAURI. "We've managed to grow steadily while maintaining lean operations, focusing on efficient structures that keep unnecessary costs low. The success
Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards8.11.2024 03:00:00 CET | Press release
The regional accolade recognizes commitment to global expansion and customer support LANSDALE, PA / ACCESSWIRE / November 8, 2024 / Greene Tweed, a global leader in advanced materials and high-performance solutions, has been honored as the Nottinghamshire "Excellence in International Trade" recipient of the 2024 East Midlands Chamber Business Awards, which celebrate the achievement and resilience of companies throughout the region. The East Midlands Chamber plays a vital role in connecting, supporting, and championing businesses and communities across Derbyshire, Leicestershire and Nottinghamshire in the United Kingdom. The Nottinghamshire Business Awards recently celebrated outstanding achievements in the local business community, where winners across 13 categories were announced. The "Excellence in International Trade" award specifically recognizes local businesses that excel in overseas trade. As one of five finalists in the category, Greene Tweed was selected for its robust growth
Polaris Renewable Energy Announces Fixed Income Meetings8.11.2024 01:00:00 CET | Press release
TORONTO, ON / ACCESSWIRE / November 8, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") announces today that it has engaged Pareto Securities as lead manager to arrange a series of fixed income meetings with potential eligible investors. Subject to market conditions and acceptable terms, the Company may issue a rated five-year tenor green bond on a private placement basis. The use of proceeds would be used to refinance certain existing debt facilities, the acquisition of the Punta Lima wind farm in Puerto Rico and other investments in renewable energy assets. S&P Global Ratings is expected to provide corporate and instrument ratings. The contemplated bond would be issued under the Company's green finance framework with second-party opinion from Morningstar Sustainalytics. The bonds have not been and will not be qualified for distribution in any province or territory of Canada. Accordingly, the bonds may not be offered or sold within any such province or terri
Innodata Reports Third Quarter 2024 Results; Record 136% Revenue Growth Year-Over-Year7.11.2024 17:00:00 CET | Press release
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / INNODATA INC. (Nasdaq: INOD) today reported results for the third quarter ended September 30, 2024. Revenue of $52.2 million, 136% revenue growth year-over-year. Net income of $17.4 million, or $0.60 per basic share and $0.51 per diluted share, compared to net income of $0.4 million, or $0.01 per basic and diluted share, in the same period last year. Third quarter net income included a $5.6 million benefit as a result of recognizing a deferred tax asset that related to our accumulated net operating losses and other deferred expenses from prior periods. Adjusted EBITDA of $13.9 million, an increase of 337% from $3.2 million in the same period last year.* Cash, cash equivalents and short-term investments of $26.4 million at September 30, 2024 and $13.8 million at December 31, 2023. Guidance raised to between 88% and 92% year-over-year revenue growth for full year 2024. *Adjusted EBITDA is defined below. Jack Abuhoff, CEO, said "Innodata cont
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom